Research Blog Archive — Page 9 of 16
-
June 25, 2015
Grant to spur study of ‘brown fat’s’ metabolic mysteries
Vanderbilt researchers have received a $2.15 million grant to study the amount and activity of “brown fat” in adults, with the aim of understanding its role in metabolic disease and identifying new therapeutic targets. -
June 25, 2015
VEI receives grant from Research to Prevent Blindness for research and education
The Vanderbilt Eye Institute recently received a grant for $115,000 from Research to Prevent Blindness, placing the total award amount for unrestricted grants from the organization at $860,000. -
June 22, 2015
Biochemistry professor Richard Armstrong remembered
Richard N. Armstrong, Ph.D., professor of Biochemistry and Chemistry, prominent biochemist, journal editor and mentor, died on June 18 after a brief illness. He was 66. -
June 17, 2015
Grant significantly expands Vanderbilt’s autism training for Tennessee educators
The Tennessee Department of Education (TDOE) has awarded a five-year, $10 million training grant to Vanderbilt Kennedy Center’s Treatment and Research Institute for Autism Spectrum Disorders (TRIAD), continuing a 16-year partnership to provide education and training opportunities for school personnel throughout the state. -
June 4, 2015
Dalley’s contributions to anatomical sciences recognized
Arthur Dalley, Ph.D., professor of Cell and Developmental Biology at Vanderbilt, recently received the highest education award for human anatomy education in the anatomical sciences during the 2015 Experimental Biology meeting in Boston. -
May 14, 2015
Jansen’s cancer research efforts garner recognition
Valerie Malyvanh Jansen, M.D., Ph.D., a third-year medical oncology fellow, recently received several national awards and grants, as well as a Vanderbilt-Ingram Cancer Center fellowship, in recognition of her translational cancer research. -
April 30, 2015
VICC cancer research efforts in spotlight at AACR conference
Adding an investigational drug to an already approved estrogen blocking therapy appears to be safe and provided clinical benefit for some postmenopausal women with estrogen-positive breast cancer.